Get started
Author

Pauline L. de Goeje

Observed names: Goeje, Pauline, P. de Goeje, Pauline L de Goeje, Pauline de Goeje, de Goeje, Pauline
ORCID: 0000-0001-5680-4495
Observed ORCID: 0000-0001-5680-4495
OpenAlex ID: A5031007260
Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy
2014 · Kristel Kemper, Pauline L. de Goeje, et al. · Cancer Research · 215
Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer
2015 · Pauline L de Goeje, Koen Bezemer, et al. · OncoImmunology · 99
PDF
Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2017 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al. · Clinical Cancer Research · 91
Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non–small Cell Lung Cancer Patients
2019 · Pauline L. de Goeje, Myrthe Poncin, et al. · Clinical Cancer Research · 43
Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS
2018 · Pauline L. de Goeje, Yarne Klaver, et al. · Frontiers in Immunology · 22
PDF
High prevalence of cardiovascular disease in South Asians: Central role for brown adipose tissue?
2015 · Mariëtte R. Boon, Leontine E. H. Bakker, et al. · Critical Reviews in Clinical Laboratory Sciences · 20
Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer
2017 · Pauline L. de Goeje, Egbert F. Smit, et al. · American Journal of Respiratory and Critical Care Medicine · 11
Undergraduate education as catalyst for public–private partnership in biotechnology
2025 · Toine ten Broeke, Thijs Koorman, et al. · Nature Biotechnology · 3
Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors
2019 · D. Dumoulin, P. de Goeje, et al. · Annals of Oncology · 3
Supplementary Data from Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non–small Cell Lung Cancer Patients
2026 · Pauline L. de Goeje, Myrthe Poncin, et al.
Data from Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non–small Cell Lung Cancer Patients
2026 · Pauline L. de Goeje, Myrthe Poncin, et al.
148P HexaBody-OX40: A novel Fcγ receptor crosslinking-independent OX40-targeting antibody, exhibits agonistic activity in vitro and antitumor activity in vivo
2023 · K. Kemper, M. Köhne, et al. · Immuno-Oncology Technology
PDF
Supplementary Data from Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2023 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al.
Data from Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2023 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al.
Data from Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2023 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al.
Supplementary Data from Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
2023 · Joachim G.J.V. Aerts, Pauline L. de Goeje, et al.
PDF
Works count: 18
Citation count: 507
H-index: 7
I10-index: 7
Year
Topic
Type